---
title: 'Design of the multicentre randomised controlled BENTO trial to demonstrate
  patient-relevant benefit of bronchoscopic lung volume reduction using thermal vapour
  ablation in the German healthcare system for patients with upper lobe emphysema:
  a study protocol'
date: '2024-05-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38806430/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240529181135&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Application of vapour ablation as a novel approach to
  lung volume reduction has positive effects in patients with severe emphysema. The
  BENTO study is a randomised, controlled, open, multicentre trial, to assess the
  effects of bronchoscopic thermal vapour ablation (BTVA) in the German healthcare
  ...'
disable_comments: true
---
INTRODUCTION: Application of vapour ablation as a novel approach to lung volume reduction has positive effects in patients with severe emphysema. The BENTO study is a randomised, controlled, open, multicentre trial, to assess the effects of bronchoscopic thermal vapour ablation (BTVA) in the German healthcare ...